ESR1 and breast cancer: Scherbakov et al. observed that a high dose (50 μmol/L) of apigenin, genistein, quercetin or naringenin showed comparable apoptotic effects in ER+ and ER− breast cancer cell lines [52], suggesting that the cytotoxic effects were not mediated by ER.